You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sclerosing Cholangitis— a Manifestation of Systemic Disease

Increased Serum {gamma}-Globulin, Follicular Lymph Node Hyperplasia, and Orbital Pseudotumor

JULIUS WENGER, MD; G. W. GINGRICH, MD; JOSEPH MENDELOFF, MD

Arch Intern Med. 1965;116(4):509-514.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE RARE disease called sclerosing cholangitis has been described in detail only 22 times in the past 40 years. Most publications are concerned with the clinical characteristics, pathology, and therapy of the inflammatory lesion which involves the extrahepatic bile ducts. The clinical picture is characterized by jaundice due to biliary tract obstruction caused by a diffuse, inflammatory thickening of the ductal walls. The ducts have been described as "cord-like" and on palpation at surgery are often said to feel like "thrombosed blood vessels." The diffuse sclerosis of the extrahepatic bile ducts, without evidence of neoplasm by histologic examination, is the major abnormality in this disease. The pathologic process may involve the entire ductal system or may be limited to the common or hepatic ducts. The mortality in most reported series is quite high, ranging from 20% to 50%, but long term follow-up studies are lacking.1,2 Differentiation from benign stricture, . . . [Full Text PDF of this Article]


Author Affiliations

ATLANTA

From the Medical, Surgical, and Pathology Services of the Atlanta Veterans Administration Hospital and Emory University School of Medicine, Atlanta. Associate Professor of Medicine (Dr. Wenger); Associate Professor of Pathology (Dr. Gingrich); and Associate Professor of Surgery (Dr. Mendeloff).


Footnotes

Received for publication Oct 16, 1964; accepted March 2, 1965.

Reprint requests to Veterans Administration Hospital, 4158 Peachtree Rd NE, Atlanta, Ga 30319 (Dr. Wenger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.